LifeMD (LFMD) vs P3 Health Partners (PIII)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
LifeMD (LFMD) has outperformed P3 Health Partners (PIII) over the past year, losing 62.5% versus a loss of 70.4%. Over five years, LFMD leads with a -65.9% price change compared with -99.7% for PIII. P3 Health Partners is the larger company by market cap ($350.2 million vs $69.8 million), about 5.0 times the size, while LifeMD is growing revenue faster (+25.3% vs -2.8%).
LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -10.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFMD | PIII |
|---|---|---|
| Share price | $1.45 | $1.69 |
| Market cap | $69.84M | $350.24M |
| 1-day change | -9.40% | -9.14% |
| YTD return | -57.62% | -51.58% |
| 1-year return | -62.47% | -70.40% |
| 5-year return | -65.92% | -99.66% |
| Forward P/E | 9.32 | — |
| EPS (TTM) | $-0.52 | $-23.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $194.06M | $1.46B |
| Revenue growth (YoY) | +25.34% | -2.76% |
| Net income (latest FY) | $14.35M | $-147.95M |
| Gross margin | 85.72% | — |
| Operating margin | -3.95% | -18.53% |
| Net margin | 7.40% | -10.14% |
| 52-week high | $5.38 | $16.89 |
| 52-week low | $1.38 | $1.52 |
| Distance from 52-week high | -73.14% | -89.99% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +462.63% | +358.58% |
| Average volume | 929.40K | 30.85K |
| Shares outstanding | 48.33M | 4.02M |
| Employees | 347 | 320 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- P3 Health Partners is about 5.0 times larger than LifeMD by market value ($350.24M vs $69.84M).
- LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -10.1 cents for P3 Health Partners.
- LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -2.76%).
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
About P3 Health Partners
PIII stock →P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.
Health Care · Medical/Nursing Services · 320 employees
LFMD vs PIII FAQ
Which is bigger, LifeMD or P3 Health Partners?
P3 Health Partners (PIII) is larger, with a market capitalization of $350.24M compared with $69.84M for LifeMD (LFMD).
Which stock has performed better over the past year, LFMD or PIII?
LFMD returned -62.47% over the past 12 months, compared with -70.40% for PIII (price return, excluding dividends). Past performance does not predict future results.
Are LifeMD and P3 Health Partners in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.